Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Insomnia can predict the appearance of back pain in adults

  • Parkinson's: Small molecules researched for the regeneration of dopaminergic neurons

  • Why some antidepressants may initially worsen symptoms

  • Autism, intellectual disability studied in quest for new treatment approaches

  • Tackling neurotransmission precision

  • Of bugs and brains: Striking similarities in brain structures across invertebrates

  • Neuro-oncologists discover cancer cells can burn acetate for fuel

  • Parkinson's disease reverted at experimental stage

  • The dementia that is not Alzheimer's disease

  • First successful vaccination against 'mad cow'-like wasting disease in deer

  •